Streetbeat News

Products Services

TSLA

Tesla has been granted U.S. Patent #11686384 for a method of making an electric drive unit having a gear shaft and rotor shaft with three bearings, potentially improving the efficiency and durability of its electric vehicles.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:25 am

GOOGL

QCOM

The first comprehensive leaks of Samsung's Galaxy Z Flip 5 reveal a 3.4-inch cover display and a droplet-style folding technique. Samsung and Alphabet's Google have reportedly teamed up to offer customized Google apps for the cover display. The phone is expected to launch in the last week of July.

Portfolio Pulse from Rounak Jain

June 27, 2023 | 9:23 am

MSFT

NVDA

SNOW

Snowflake Inc is partnering with NVIDIA Corp to help businesses create customized generative AI applications using their proprietary data in the Snowflake Data Cloud. The integration of NVIDIA NeMo with Snowflake will enable enterprises to build custom LLMs for advanced AI services. Snowflake also recently expanded its partnership with Microsoft.

Portfolio Pulse from Lekha Gupta

June 27, 2023 | 9:19 am

MSFT

TRI

Thomson Reuters Corp (NYSE:TRI) has agreed to acquire California-based legal technology provider Casetext for $650 million in cash. The acquisition will complement Thomson Reuters' AI roadmap and build on its recent initiatives, including a planned investment of over $100 million annually on AI capabilities.

Portfolio Pulse from Lekha Gupta

June 27, 2023 | 9:10 am

GSK

The FDA has granted Fast Track designation for GSK's Neisseria Gonorrhoeae investigational vaccine, which is currently in Phase 2 trial and aims to assess the efficacy of the vaccine in healthy adults considered at risk of gonorrhea.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 9:04 am

AZN

AstraZeneca's Xigduo XR has received approval from China's National Medical Products Administration for use in adults with type-2 diabetes as an adjunct to diet and exercise to improve glycemic control.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 8:25 am

SNY

Sanofi announced that its Phase 2B (STREAM-AD) study of Amlitelimab in adults with moderate-to-severe atopic dermatitis met its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 8:23 am

SPCE

Virgin Galactic announced its first commercial spaceflight, Galactic 01, is scheduled for June 29. The mission will be a research mission for the Italian Air Force and will include 13 scientific research experiments. The company's commercial service launch remains on track for Q2 2023.

Portfolio Pulse from Anan Ashraf

June 27, 2023 | 8:07 am

VRNA

Verona Pharma has submitted a New Drug Application (NDA) to the US FDA for approval of ensifentrine, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 7:24 am

LLY

Eli Lilly (NYSE:LLY) has reported promising results for its experimental drug retatrutide, which led to 24.2% weight loss in a mid-stage trial. If successful in Phase 3 trials, it could propel Lilly ahead of competitors in the obesity treatment market.

Portfolio Pulse from Benzinga Newsbot

June 27, 2023 | 5:26 am